HCPCS Level IIdrugActive
J3473
Hyaluronidase recombinant
BETOS: O1E
Effective: 2007-01-01
Referenced in 2 policies
Description
Injection, hyaluronidase, recombinant, 1 usp unit
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Hylenex
Manufacturer
Antares Pharma, Inc.
HCPCS Dosage
1 USP UNIT
Billing Units
150.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.